Showing results (131-140 of 198) with videos related to
Sort By:
Pageof 20
Cancer Management and Research|September 5, 2020
Predictors of Intravesical Recurrence After Radical Nephroureterectomy and Prognosis in Patients with Upper Tract Urothelial CarcinomaYun-Ren Li, Kai-Jie Yu, Ying-Hsu Chang, et al.Small (Weinheim an Der Bergstrasse, Germany)|August 6, 2024
Lab-in-a-Vial Rapid Test for Internet of Things-Embedded Point-of-Healthcare Protein Biomarker Detection in Bodily FluidsNan-Si Li, Ying-Pei Hsu, Hao-Han Pang, et al.Academic Radiology|September 4, 2025
Automated Kidney Tumor Segmentation in CT Images Using Deep Learning: A Multi-Stage ApproachHung-Cheng Kan, Geng-Ming Fan, Ming-Hao Wei, et al.Chang Gung Medical Journal|February 27, 2010
Characterization of the response of dendritic cells and regulatory T cells to tumor antigens in patients with renal cell carcinomaMing-Mo Hou, John Wen-Cheng Chang, See-Tong Pang, et al.Cancer Medicine|February 27, 2023
RP11-367G18.1 V2 enhances clear cell renal cell carcinoma progression via induction of epithelial-mesenchymal transitionI-Hung Shao, Pei-Hua Peng, Heng-Hsiung Wu, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|April 22, 2026
Niraparib With Abiraterone Acetate Plus Prednisone as First-Line Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer With Homologous Recombination Repair Gene Alterations: Final Analysis of the Asian Subgroup From the MAGNITUDE StudyDingwei Ye, Marniza Saad, Ji Youl Lee, et al.International Journal of Cancer|June 26, 2024
Real-world safety and effectiveness of radium-223 in patients with metastatic castration-resistant prostate cancer: Interim analyses of the prospective, observational RAPIT studyChao-Yuan Huang, Chi-Ping Huang, Yu-Yi Huang, et al.Journal of Oncology|September 6, 2021
Prostate-Specific Antigen Kinetics Effects on Outcomes of Low-Volume Metastatic Prostate Cancer Patients Receiving Androgen Deprivation TherapyYen-Chi Lin, Po-Hung Lin, I-Hung Shao, et al.Cancers|August 14, 2025
Predicting Cardiovascular Risk in Patients with Prostate Cancer Receiving Abiraterone or Enzalutamide by Using Machine LearningDong-Yi Chen, Chun-Chi Chen, Ming-Lung Tsai, et al.Nucleic Acids Research|October 29, 2013
REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancerCharlotte Svensson, Jens Ceder, Diego Iglesias-Gato, et al.Pageof 20